Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2025-11-14 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a press release from SVAS Biosana S.p.A. titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Report on Treasury Share Purchases). It details the specific number of shares purchased, the average price, and the total value of the transactions conducted between November 10 and November 14, 2025, under an authorized share buyback program. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2025-11-14 Italian
Dimissioni Amministratore Delegato
Board/Management Information Classification · 100% confidence The document is a press release announcing the resignation of the CEO and Board Member (Umberto Perillo) and the subsequent reallocation of his operational duties to the Chairman. It also mentions the convocation of a shareholders' meeting to address the reduction in the number of board members. This falls squarely under the definition of a management change announcement.
2025-11-10 Italian
Ricavi consolidati al 30.09.2025 e informativa
Earnings Release Classification · 100% confidence The document is a press release from Svas Biosana S.p.A. announcing consolidated revenue results for the nine-month period ending September 30, 2025. It provides key financial highlights, revenue growth percentages, and business unit performance, which are characteristic of an Earnings Release (ER). Although it also contains a section regarding a legal matter, the primary purpose and structure of the document are to communicate the periodic financial performance to the market. 9M 2025
2025-11-07 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a weekly press release from Svas Biosana S.p.A. detailing the purchase of its own shares (buyback program) over a specific period (November 3-7, 2025). It provides a table of daily transactions, the total number of shares held, and the percentage of share capital. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2025-11-07 Italian
Modifica azionista significativo
Major Shareholding Notification Classification · 100% confidence The document is a press release from Svas Biosana S.p.A. announcing that a significant shareholder, Anima SGR S.p.A., has reduced its stake below the 5% threshold. This is a classic notification of a change in major shareholding, which falls under the 'Major Shareholding Notification' category.
2025-11-05 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a weekly press release from Svas Biosana S.p.A. detailing the purchase of its own shares (share buyback) over a specific period (October 27 to October 31, 2025). It includes a table of daily transactions, the total number of shares held, and the average price. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-10-31 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.